BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 15, 2003
View Archived Issues
New data on memantine in moderate to severe Alzheimer's disease
Read More
Intracellular fate of NB-1011 characterized by NewBiotics scientists
Read More
Optimization of farnesyltransferase inhibitors described at ACS by Pharmacopeia
Read More
RXR modulators as novel therapies for type 2 diabetes
Read More
Probiodrug presents DPP-I inhibitors for use in cancer and other diseases
Read More
New series of platelet ADP receptor inhibitors identified at Millennium
Read More
Antitumor duocarmycin analogues claimed by researchers at Scripps Research Institute
Read More
Euroceltique scientists prepare and test novel sodium channel blockers
Read More
New NPY Y5 receptor modulators in early development at AstraZeneca
Read More
Roche presents new CCR3 receptor antagonists and their use in asthma therapy
Read More
Data safety monitoring board recommends continuation of Fibrillex phase II/III trial
Read More
New Rapamune indication approved
Read More
StemCells granted patent for methods of isolating pancreatic progenitor cells
Read More
Affitech and NatImmune collaborate in colon cancer
Read More
Phase I IND amendment for Oxycyte submitted
Read More
Alizyme completes enrollment of phase IIb trial of renzapride
Read More
AG-858/Gleevec combination therapy subject of new phase II trial in CML
Read More
Tolvaptan shows no signs of drug interactions with warfarin or amiodarone
Read More
Efficacy results reported from pilot phase IIa study of DB-289 in pneumonia
Read More
FDA lifts clinical hold on trials of MacroChem's SEPA-based drugs
Read More
OSI updates Tarceva program progress
Read More
Pharmacokinetics and metabolism of bazedoxifene assessed in postmenopausal women
Read More
Orally active, nonemetogenic PDE4 inhibitor shows respiratory antiinflammatory activity
Read More
AWD-33-159: a structurally and mechanistically novel anticonvulsant
Read More
Macrocyclic thrombin inhibitors with high potency and selectivity
Read More